Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2016 | 1 |
2019 | 1 |
2021 | 2 |
2022 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
Page 1
Long-term evolution of neuroendocrine cell hyperplasia of infancy: the FRENCHI findings.
Eur J Pediatr. 2023 Feb;182(2):949-956. doi: 10.1007/s00431-022-04734-y. Epub 2022 Nov 30.
Eur J Pediatr. 2023.
PMID: 36449078
Only few studies report long-term evolution of patients with neuroendocrine cell hyperplasia of infancy (NEHI). ...What is Known: Neuroendocrine cell hyperplasia of infancy (NEHI) is an interstitial lung disease whose long-term outcome is considered positive from ve …
Only few studies report long-term evolution of patients with neuroendocrine cell hyperplasia of infancy (NEHI). ...What is Known: Neu …
Health-related quality of life in infants and children with interstitial lung disease.
Lauby C, Boelle PY, Abou Taam R, Bessaci K, Brouard J, Dalphin ML, Delacourt C, Delestrain C, Deschildre A, Dubus JC, Fayon M, Giovannini-Chami L, Houdouin V, Houzel A, Marguet C, Pin I, Reix P, Renoux MC, Schweitzer C, Tatopoulos A, Thumerelle C, Troussier F, Wanin S, Weiss L, Clement A, Epaud R, Nathan N.
Lauby C, et al. Among authors: troussier f.
Pediatr Pulmonol. 2019 Jun;54(6):828-836. doi: 10.1002/ppul.24308. Epub 2019 Mar 13.
Pediatr Pulmonol. 2019.
PMID: 30868755
The clinical factors associated with a lower total score were: extrapulmonary expression of the disease, higher Fan severity score, long-term oxygen therapy, nutritional support, and a number of oral treatments. ...
The clinical factors associated with a lower total score were: extrapulmonary expression of the disease, higher Fan severity score, long- …
Item in Clipboard
Rapid Improvement after Starting Elexacaftor-Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis and Advanced Pulmonary Disease.
Burgel PR, Durieu I, Chiron R, Ramel S, Danner-Boucher I, Prevotat A, Grenet D, Marguet C, Reynaud-Gaubert M, Macey J, Mely L, Fanton A, Quetant S, Lemonnier L, Paillasseur JL, Da Silva J, Martin C; French Cystic Fibrosis Reference Network Study Group.
Burgel PR, et al.
Am J Respir Crit Care Med. 2021 Jul 1;204(1):64-73. doi: 10.1164/rccm.202011-4153OC.
Am J Respir Crit Care Med. 2021.
PMID: 33600738
The mean (95% confidence interval) absolute increase in the ppFEV(1) was +15.1 (+13.8 to +16.4; P < 0.0001), and the mean (95% confidence interval) in weight was +4.2 kg (+3.9 to +4.6; P < 0.0001). The number of patients requiring long-term oxygen, noninvasive ventil
…The mean (95% confidence interval) absolute increase in the ppFEV(1) was +15.1 (+13.8 to +16.4; P < 0.0001), and the mean (95% confidence
…
Item in Clipboard
Correction to: Real-World Long-Term Ivacaftor for Cystic Fibrosis in France: Clinical Effectiveness and Healthcare Resource Utilization.
Hubert D, Marguet C, Benichou J, DeSouza C, Payen-Champenois C, Kinnman N, Chandarana K, Munck A, Fajac I; BRIO Study Group.
Hubert D, et al.
Pulm Ther. 2021 Dec;7(2):469-470. doi: 10.1007/s41030-021-00165-6.
Pulm Ther. 2021.
PMID: 34260039
Free PMC article.
No abstract available.
Item in Clipboard
Long-Term Rasamsonia argillacea Complex Species Colonization Revealed by PCR Amplification of Repetitive DNA Sequences in Cystic Fibrosis Patients.
Mouhajir A, Matray O, Giraud S, Mély L, Marguet C, Sermet-Gaudelus I, Le Gal S, Labbé F, Person C, Troussier F, Ballet JJ, Gargala G, Zouhair R, Bougnoux ME, Bouchara JP, Favennec L.
Mouhajir A, et al. Among authors: troussier f.
J Clin Microbiol. 2016 Nov;54(11):2804-2812. doi: 10.1128/JCM.01462-16. Epub 2016 Sep 7.
J Clin Microbiol. 2016.
PMID: 27605712
Free PMC article.
Item in Clipboard
Cite
Cite